Legal & General Group’s Maze Therapeutics, Inc. Common Stock MAZE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$52K Buy
4,242
+3,371
+387% +$41.4K ﹤0.01% 2705
2025
Q1
$9.59K Buy
+871
New +$9.59K ﹤0.01% 3178